LRMR

News Larimar Therapeutics Stock Falls After Patients Report Allergic Reaction In Pivotal Study

14d ago

News Larimar Beats Q2 Loss Estimates

14d ago

News Biotech Stock Roundup: BIIB's Acquisition, PTCT, LRMR Gain on Updates & More News

14d ago

News Larimar Therapeutics' Friedreich's Ataxia Investigational Drug Differentiated From Biogen's Marketed Drug

14d ago

SEC filing LRMR Reports $115M Offering, $244.5M Cash, Breakthrough Therapy for FA, BLA June 2026, Phase 3 Q2 2026

75d ago

SEC filing LRMR Reports $244.5M Cash Runway to 2027, Proposes $50M Buyback, Advances Nomlabofusp for FA

84d ago

Insider trade Purchase by James E Flynn / DEERFIELD MANAGEMENT COMPANY, L.P. / Deerfield Mgmt III, L.P. / Deerfield Mgmt HIF, L.P. / Deerfield Mgmt IV, L.P. / Mgmt L.P. Deerfield / Deerfield Private Design Fund III, L.P. / Deerfield Healthcare Innovations Fund, L.P. / Deerfield Private Design

91d ago

Insider trade Purchase by Thomas Edward Hamilton

91d ago

Insider trade Purchase by Frank E Thomas

91d ago

Insider trade Purchase by Jeffrey W Sherman

91d ago

News Larimar Therapeutics Announces Pricing of Upsized $100 Million Underwritten Public Offering

96d ago

News Larimar surges on FDA breakthrough status for lead asset

98d ago

News Larimar Therapeutics, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – LRMR

153d ago

Scanner Unusual volume (z=3.9)

166d ago